GAITHERSBURG, Md., April 30, 2020 (GLOBE NEWSWIRE) — Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe […]
MALVERN, Penn., April 30, 2020 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing […]
Disciplined execution generated solid results in line with our expectationsPrioritizing safety and well-being of team members, customers and communitiesOperationally and […]